trial

Repetitive Transcranial Magnetic Stimulation for "Voices"

NCTId NCT00004980
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 50 (actual)
Sponsored by Yale University
Primary completion 2005-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
1999-12
Primary completion
2005-01
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation (rTMS)

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Ralph E. Hoffman, MDStudy Chair

Sites

1 total
New Haven, United States

Linked catalysts

1
Repetitive Transcranial Magnetic Stimulation for "Voices" — primary completion2005-01

Facts & assertions

4 sourced
Enrollment
50
Phase
PHASE2
Primary Completion Date
2005-01
Status
COMPLETED
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation (rTMS)
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Neurologic Manifestations
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Ralph E. Hoffman, MD
person